XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.3
MARKETABLE SECURITIES
9 Months Ended
Sep. 30, 2024
MARKETABLE SECURITIES  
MARKETABLE SECURITIES

5. MARKETABLE SECURITIES:

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at September 30, 2024, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Commercial paper

$

748

$

$

$

748

Total

 

748

 

 

 

748

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Corporate securities

92,943

269

(26)

93,186

Total

 

92,943

 

269

 

(26)

 

93,186

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

 

148,720

 

2,634

 

(6)

 

151,348

Total

148,720

 

2,634

(6)

 

151,348

Total marketable securities

$

242,411

$

2,903

$

(32)

$

245,282

Accrued interest receivable was $2.6 million at September 30, 2024 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.

Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at December 31, 2023, were as follows:

Amortized

Gross Unrealized

Estimated Fair

(In thousands)

    

Cost

    

Gains

    

Losses

    

Market Value

Investments due in 3 months or less:

 

  

 

  

 

  

 

  

Corporate securities

$

10,688

$

$

(42)

$

10,646

Total

 

10,688

 

 

(42)

 

10,646

Investments due in 4-12 months:

 

  

 

  

 

  

 

  

Commercial paper

718

718

Corporate securities

 

48,680

 

15

 

(347)

 

48,348

Total

 

49,398

 

15

 

(347)

 

49,066

Investments due in 12 months or greater:

 

  

 

  

 

  

 

  

Corporate securities

187,298

 

952

 

(322)

 

187,928

Total

 

187,298

 

952

 

(322)

 

187,928

Total marketable securities

$

247,384

$

967

$

(711)

$

247,640

Accrued interest receivable was $2.3 million at December 31, 2023 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet.

The following table summarizes marketable securities classified as available-for-sale (excluding cash equivalents) in a continuous unrealized loss position for which an allowance for credit losses was not recorded at September 30, 2024:

Less Than 12 Months

12 Months or Longer

Total

    

Estimated

    

Gross

    

Estimated

    

Gross

    

Estimated

    

Gross

Fair Market

Unrealized

Fair Market

Unrealized

Fair Market

Unrealized

(In thousands)

Value

Losses

Value

Losses

Value

Losses

Corporate securities

$

10,790

$

(9)

$

13,222

$

(23)

$

24,012

$

(32)

Total marketable securities

$

10,790

$

(9)

$

13,222

$

(23)

$

24,012

$

(32)

In the three and nine months ended September 30, 2024 and 2023, no unrealized losses on marketable securities were recognized in income.

The Company does not intend to sell and it is unlikely that it will be required to sell the securities prior to their anticipated recovery. The issuers are high quality (investment grade) and the decline in fair value is largely due to changes in interest rates. Additionally, the issuers continue to make timely interest payments on the marketable securities with the fair value expected to recover as they reach maturity.